IT8320550A0 - PERAFFINITY PURIFICATION PROCEDURE IN WHICH MONOCLONAL ANTIBODIES ARE USED. - Google Patents

PERAFFINITY PURIFICATION PROCEDURE IN WHICH MONOCLONAL ANTIBODIES ARE USED.

Info

Publication number: IT8320550A0
Authority: IT; Italy
Prior art keywords: peraffinity; monoclonal antibodies; purification procedure; purification; procedure
Prior art date: 1982-04-12

Application number

IT8320550A

Other languages

Italian (it)

Other versions

IT1219779B (en

Inventor

Richard M Bartholomew

Daniel E Beidler

Gary S David

Original Assignee

Hybritech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-04-12

Filing date

1983-04-12

Publication date

1983-04-12

1983-04-12 Application filed by Hybritech Inc filed Critical Hybritech Inc

1983-04-12 Publication of IT8320550A0 publication Critical patent/IT8320550A0/en

1990-05-24 Application granted granted Critical

1990-05-24 Publication of IT1219779B publication Critical patent/IT1219779B/en

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

IT20550/83A 1982-04-12 1983-04-12 PURIFYING PROCESS FOR AFFINITY IN WHICH MONOCLONAL ANTIBODIES ARE USED IT1219779B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US36778182A	1982-04-12	1982-04-12

Publications (2)

Publication Number	Publication Date
IT8320550A0 true IT8320550A0 (en)	1983-04-12
IT1219779B IT1219779B (en)	1990-05-24

Family

ID=23448565

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IT20550/83A IT1219779B (en)	1982-04-12	1983-04-12	PURIFYING PROCESS FOR AFFINITY IN WHICH MONOCLONAL ANTIBODIES ARE USED

Country Status (11)

Country	Link
EP (1)	EP0105359A4 (en)
AT (1)	AT393386B (en)
AU (1)	AU622099B2 (en)
CA (1)	CA1209907A (en)
CH (1)	CH672028A5 (en)
DK (1)	DK192191D0 (en)
ES (3)	ES521371A0 (en)
FI (1)	FI88403C (en)
GB (1)	GB2128630B (en)
IT (1)	IT1219779B (en)
WO (1)	WO1983003678A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8328918D0 (en) *	1983-10-28	1983-11-30	Unilever Plc	Alkaline phosphatase
GB8331071D0 (en) *	1983-11-22	1983-12-29	Karayiannis P	Assay for dna/rna
US4666865A (en) *	1984-01-13	1987-05-19	Centocor, Inc.	Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
US4789631A (en) *	1984-02-17	1988-12-06	Synbiotics Corporation	Immunoassay for anti-dirofilaria immitis antibody
GB8426468D0 (en) *	1984-10-19	1984-11-28	Technology Licence Co Ltd	Monoclonal antibodies
AU5259786A (en) *	1985-01-30	1986-08-07	United States Of America, The	Monoclonal antibodies against chlamydial genes specific lipopolysaccharide
US4859611A (en) *	1985-02-28	1989-08-22	Massachusetts Institute Of Technology	Affinity column and process for detection of low molecular weight toxic substances
US4818687A (en) *	1985-02-28	1989-04-04	Massachusetts Institute Of Technology	Affinity column and process for detection of low molecular weight toxic substances
IL75828A (en) *	1985-07-17	1991-06-10	Univ Ramot	Immobilization by biologically active proteins
NZ218336A (en) *	1985-12-09	1991-08-27	Kirin Amgen Inc	Monoclonal antibodies to human pluripotent granulocyte colony stimulating factor (hpg-csf)
US5175255A (en) *	1987-03-23	1992-12-29	Amgen Inc.	Methods for purification of platelet-derived growth factor
US5190859A (en) *	1987-02-26	1993-03-02	Dana-Farber Cancer Institute, Inc.	Purification of LFA-3
SE468653B (en) *	1987-03-06	1993-02-22	Perstorp Biolytica	ADSORBENT FOR ISOCRATIC AFFINITY CHROMATOGRAPHY
JPS6463599A (en) *	1987-05-01	1989-03-09	Xoma Corp	Purification of immunoglobulin by selective anti-idiotype bond
WO1989000695A1 (en) *	1987-07-14	1989-01-26	The Victoria University Of Manchester	Method for the diagnosis of infections with detection of lipopolysaccharide antigens
CA1323567C (en) *	1987-10-05	1993-10-26	Gene R. Nathans	Method for purification of antibodies
US5372812A (en) *	1988-04-04	1994-12-13	The General Hospital Corporation	Composition and method for acceleration of clot lysis
US5582862A (en)	1988-04-04	1996-12-10	General Hospital Corporation	Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
AU741338B2 (en) *	1996-09-20	2001-11-29	Bristol-Myers Squibb Company	Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
PL3514180T3 (en) *	2008-04-11	2024-08-12	Chugai Seiyaku Kabushiki Kaisha	Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
TWI812066B (en)	2010-11-30	2023-08-11	日商中外製藥股份有限公司	Antibody having calcium-dependent antigen-binding ability
WO2012115241A1 (en)	2011-02-25	2012-08-30	中外製薬株式会社	Fcγriib-specific fc antibody
JP6322411B2 (en)	2011-09-30	2018-05-09	中外製薬株式会社	Antigen-binding molecules that promote the disappearance of antigens with multiple physiological activities
CN104080909A (en)	2011-11-30	2014-10-01	中外制药株式会社	Drug containing carrier into cell for forming immune complex
SG11201607165YA (en)	2014-12-19	2016-09-29	Chugai Pharmaceutical Co Ltd	Anti-c5 antibodies and methods of use
AR103161A1 (en)	2014-12-19	2017-04-19	Chugai Pharmaceutical Co Ltd	ANTIMIOSTATINE ANTIBODIES AND VARIANTS FC REGIONS AS WELL AS METHODS OF USE
US11359009B2 (en)	2015-12-25	2022-06-14	Chugai Seiyaku Kabushiki Kaisha	Anti-myostatin antibodies and methods of use
TW202300168A (en)	2016-08-05	2023-01-01	日商中外製藥股份有限公司	Composition for prophylaxis or treatment of il-8 related diseases
JP7191833B2 (en)	2017-01-30	2022-12-19	中外製薬株式会社	Anti-sclerostin antibodies and uses thereof
CN110724204B (en) *	2019-11-18	2021-10-22	广东菲鹏制药股份有限公司	Method for purifying Fc fusion protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4172124A (en) *	1978-04-28	1979-10-23	The Wistar Institute	Method of producing tumor antibodies
EP0059598B1 (en) *	1981-02-26	1985-07-17	Unilever Plc	A process and apparatus for the recovery of immunoglobulines
US4474893A (en) *	1981-07-01	1984-10-02	The University of Texas System Cancer Center	Recombinant monoclonal antibodies
US4361509A (en) *	1981-12-14	1982-11-30	Scripps Clinic And Research Foundation	Ultrapurification of factor VIII using monoclonal antibodies

1983
- 1983-04-11 CA CA000425555A patent/CA1209907A/en not_active Expired
- 1983-04-11 ES ES521371A patent/ES521371A0/en active Granted
- 1983-04-12 AT AT9019/83A patent/AT393386B/en not_active IP Right Cessation
- 1983-04-12 EP EP19830901671 patent/EP0105359A4/en not_active Withdrawn
- 1983-04-12 WO PCT/US1983/000524 patent/WO1983003678A1/en not_active Application Discontinuation
- 1983-04-12 GB GB08332644A patent/GB2128630B/en not_active Expired
- 1983-04-12 IT IT20550/83A patent/IT1219779B/en active
- 1983-04-12 CH CH6699/83A patent/CH672028A5/de not_active IP Right Cessation
- 1983-12-09 FI FI834530A patent/FI88403C/en not_active IP Right Cessation
- 1983-12-13 ES ES528001A patent/ES8706964A1/en not_active Expired
- 1983-12-13 ES ES528000A patent/ES8506902A1/en not_active Expired
1987
- 1987-05-06 AU AU72569/87A patent/AU622099B2/en not_active Ceased
1991
- 1991-11-26 DK DK911921A patent/DK192191D0/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
FI834530A (en)	1983-12-09
GB8332644D0 (en)	1984-01-11
FI834530A0 (en)	1983-12-09
ES8404858A1 (en)	1984-05-16
DK192191A (en)	1991-11-26
WO1983003678A1 (en)	1983-10-27
GB2128630A (en)	1984-05-02
ES528001A0 (en)	1987-07-01
AU622099B2 (en)	1992-04-02
ES528000A0 (en)	1985-08-01
IT1219779B (en)	1990-05-24
CA1209907A (en)	1986-08-19
AT393386B (en)	1991-10-10
EP0105359A4 (en)	1984-08-20
ES8506902A1 (en)	1985-08-01
EP0105359A1 (en)	1984-04-18
ATA901983A (en)	1991-03-15
CH672028A5 (en)	1989-10-13
ES8706964A1 (en)	1987-07-01
ES521371A0 (en)	1984-05-16
AU7256987A (en)	1987-09-03
DK192191D0 (en)	1991-11-26
FI88403B (en)	1993-01-29
FI88403C (en)	1993-05-10
GB2128630B (en)	1986-08-28

Publication	Publication Date	Title
IT8320550A0 (en)	1983-04-12	PERAFFINITY PURIFICATION PROCEDURE IN WHICH MONOCLONAL ANTIBODIES ARE USED.
DE3382572D1 (en)	1992-07-09	ANTIBODY CONNECTIONS.
IT8319234A0 (en)	1983-01-21	PROCEDURE FOR THE PRODUCTION OF HUMAN MONOCLONAL ANTIBODIES.
NO162179C (en)	1989-11-22	MONOCLONAL ANTIBODIES FOR USE IN VITRO.
DE3854502D1 (en)	1995-10-26	AGAINST HIV-ANTIGENT SPECIFIC MONOCLONAL ANTIBODIES.
DE3885355D1 (en)	1993-12-09	Monoclonal antibodies.
DE3177276D1 (en)	1992-04-23	MONOCLONAL ANTIBODIES.
DK717888D0 (en)	1988-12-22	MONOCLONAL ANTIBODIES
DE3586808D1 (en)	1992-12-17	L-THYROXIN DETECTING MONOCLONAL ANTIBODIES.
DE3785795D1 (en)	1993-06-17	MONOCLONAL ANTI-HUMAN CANCER ANTIBODIES.
NO873488L (en)	1988-02-23	MONOCLONAL ANTIBODIES.
GB8616174D0 (en)	1986-08-06	Monoclonal antibodies
NO890116D0 (en)	1989-01-11	MONOCLONAL ANTIBODIES.
NO834535L (en)	1983-12-09	PROCEDURE FOR AFFINITY CLEANING USING MONOCLONAL ANTIBODIES.
DK370089A (en)	1990-02-13	ANTI-UROKINASE MONOCLONAL ANTIBODIES
ES514167A0 (en)	1983-04-01	"PROCEDURE FOR OBTAINING BENZHIDRILPIPERAZINAS".
GB8610202D0 (en)	1986-05-29	Monoclonal antibodies
ES267636Y (en)	1984-11-01	"LUSTRADOR".
ES264864Y (en)	1983-05-16	"PESACARTAS".
IT8321492A0 (en)	1983-06-07	LYMPHOKINES AND HUMAN MONOCLONAL ANTIBODIES.
ES266069Y (en)	1983-07-16	"LIGHTER".
ES263615Y (en)	1983-10-16	"SEAT".
ES263608Y (en)	1983-04-16	"MULTIPURPOSE PLUG-PLUG".
ES268079Y (en)	1983-11-16	"MULTIPURPOSE DEVICE".
ES266129Y (en)	1984-07-01	"PERFECT SADDLE".